Pirlindole

Pirlindole
Clinical data
Trade names Pirazidol
Routes of
administration
Oral
ATC code none
Legal status
Legal status
  • ℞ (Prescription only)
Pharmacokinetic data
Bioavailability 20–30%
Protein binding 95%
Metabolism hepatic
Onset of action 2 to 8 hours
Biological half-life 185 hours
Excretion urine (50–70%), feces (25–45%)
Identifiers
CAS Number 60762-57-4
PubChem (CID) 68802
IUPHAR/BPS 6638
DrugBank DB09244 YesY
ChemSpider 62039
UNII V39YPH45FZ YesY
KEGG D08392
ChEMBL CHEMBL32350
Chemical and physical data
Formula C15H18N2
Molar mass 226.32 g/mol
3D model (Jmol) Interactive image

Pirlindole (Lifril, Pyrazidol) is a reversible inhibitor of monoamine oxidase A (RIMA) which was developed and is used in Russia as an antidepressant.[1]:337 It is structurally and pharmacologically related to metralindole.

See also

References

  1. Medvedev AE, et al. The influence of the antidepressant pirlindole and its dehydro-derivative on the activity of monoamine oxidase A and GABAA receptor binding. Chapter 36 in MAO - The Mother of all Amine Oxidases (Journal of Neural Transmission. Supplementa). Eds Finberg JPM, Youdim MBH, Riederer P, Tipton KF. Special edition of Journal of Neural Transmission, Suppl. 52 1st ed. 1998 ISBN 978-3211830376


This article is issued from Wikipedia - version of the 9/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.